Platensimycin, a New Antibiotic and “Superbug Challenger” from Nature
- 11 September 2006
- journal article
- review article
- Published by Wiley in ChemMedChem
- Vol. 1 (9), 951-954
- https://doi.org/10.1002/cmdc.200600145
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Antibacterial Natural Products in Medicinal Chemistry—Exodus or Revival?Angewandte Chemie-International Edition, 2006
- Antibakterielle Naturstoffe in der medizinischen Chemie – Exodus oder Renaissance?Angewandte Chemie, 2006
- Platensimycin is a selective FabF inhibitor with potent antibiotic propertiesNature, 2006
- Empirical antibacterial drug discovery—Foundation in natural productsBiochemical Pharmacology, 2006
- Discovery of FabH/FabF Inhibitors from Natural ProductsAntimicrobial Agents and Chemotherapy, 2006
- MRSA: status and prospects for therapy? An evaluation of key papers on the topic of MRSA and antibiotic resistanceEmerging Therapeutic Targets, 2004
- Community‐Acquired Methicillin‐ResistantStaphylococcus aureus:A Meta‐Analysis of Prevalence and Risk FactorsClinical Infectious Diseases, 2003
- 'Superbug' hurdles key drug barrierNature, 2002
- Eubacterial Diterpene Cyclase Genes Essential for Production of the Isoprenoid Antibiotic TerpentecinJournal of Bacteriology, 2001
- Increasing Prevalence of Multidrug-ResistantStreptococcus pneumoniaein the United StatesNew England Journal of Medicine, 2000